End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
62.38 CNY | -2.90% | -3.90% | -4.40% |
Apr. 19 | Jianmin Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 16 | Jianmin Pharma Gets Nod to Market Asthma Drug | MT |
Sales 2024 * | 4.93B 680M | Sales 2025 * | 5.68B 784M | Capitalization | 9.48B 1.31B |
---|---|---|---|---|---|
Net income 2024 * | 619M 85.41M | Net income 2025 * | 768M 106M | EV / Sales 2024 * | 1.92 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 1.67 x |
P/E ratio 2024 * |
15.5
x | P/E ratio 2025 * |
12.5
x | Employees | 2,497 |
Yield 2024 * |
2.5% | Yield 2025 * |
3.06% | Free-Float | 68.93% |
1 day | -2.90% | ||
1 week | -3.90% | ||
Current month | -3.90% | ||
1 month | +6.78% | ||
3 months | +16.60% | ||
6 months | -8.05% | ||
Current year | -4.40% |
Managers | Title | Age | Since |
---|---|---|---|
Jun Wang
CEO | Chief Executive Officer | 48 | 20-09-08 |
Zhao Yang Cheng
DFI | Director of Finance/CFO | 52 | 18-01-01 |
Qin He
CHM | Chairman | 64 | 03-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Qin He
CHM | Chairman | 64 | 03-12-31 |
Shu Qu Li
BRD | Director/Board Member | 53 | 19-09-04 |
Rong Pei
BRD | Director/Board Member | 53 | 11-08-02 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-07 | 62.38 | -2.90% | 1,640,200 |
24-06-06 | 64.24 | +0.45% | 2,279,265 |
24-06-05 | 63.95 | -3.11% | 1,469,860 |
24-06-04 | 66 | +2.28% | 1,847,665 |
24-06-03 | 64.53 | -0.59% | 1,346,506 |
End-of-day quote Shanghai S.E., June 06, 2024
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-4.40% | 1.31B | |
+45.82% | 765B | |
-6.16% | 354B | |
+19.86% | 331B | |
+9.32% | 299B | |
+18.45% | 248B | |
-0.78% | 219B | |
+11.88% | 216B | |
+5.90% | 164B | |
-0.73% | 162B |
- Stock Market
- Equities
- 600976 Stock